• Account Access
  • Contact Us

    Pre-Sales Support

    Mutual Funds and ETFs - 800-456-7526
    Monday-Thursday: 8:00 a.m. – 6:00 p.m. ET
    Friday: 8:00 a.m. – 5:00 p.m. ET

    ETF Trading Support - 415-315-6600
    Monday-Friday: 9:30 a.m. – 5:00 p.m. ET

    Post-Sales and Website Support
    Monday-Friday: 9:00 a.m. - 6:00 p.m. ET

  • Advisor Log In

Investable Innovation: Tracking Remarkable Biopharmaceutical Advances

May 2019 
By the Wellington Management Healthcare Team

In the coming decade, we should witness the arrival of a host of wonderful new drugs and novel treatment modalities.

Jean Hynes
Portfolio Manager for Hartford Healthcare Fund
Robert Deresiewicz, MD
Portfolio Manager for Hartford Healthcare Fund
Catherine Arnold
Global Industry Analyst
Mark Sevecka, PhD
Research Associate
Wen Shi, PhD, CFA
Global Industry Analyst
Rebecca Sykes, CFA
Global Industry Analyst


Despite recent volatility, opportunities in healthcare remain abundant and we believe the long-term outlook for the sector is positive. Powerful demographic trends, a record-setting pace of innovation, and structural changes in healthcare delivery systems continue to drive growth and expand the investment opportunity set. Wellington Management’s Healthcare team currently manages over US$60 billion in assets for clients globally.1 Several team members recently shared their views on advances in the biopharmaceutical industry around the world.

1 As of December 31, 2018. Firm assets include assets under management and non-discretionary assets.

Important Risks: Investing involves risk, including the possible loss of principal. • Risks of focusing investments on the healthcare related sector include regulatory and legal developments, patent considerations, intense competitive pressures, rapid technological changes, potential product obsolescence, and liquidity risk.

WP492 211982